| | Advanced Search

 

NEW: Providence’s Al Forno Featured as a Best Pizza Spot in the US—Another accolade for Al Forno

John Perilli: Peter Neronha, US Attorney & Rising Political Star?—He could be tough to beat...

NEW: Kate Simons Joins Shawmut Design as New Project Manager—Will manage construction projects for state's top hospitals

Local Songwriter Parodies Gordon Fox and Calamari Legislation—Check out these political parodies for yourself

Michael Riley: Rhode Island’s Potential Pension Nightmare—Headed for disaster...

Rob Horowitz: The Civil Rights Act, 50 Years Later—Celebrating a milestone...

Fund for Community Progress Honors GoLocalProv + Other RI Leaders—Recognizing outstanding contributions to the RI community

Organize + Energize: 7 Reasons to Hire a Professional Organizer—With a little help from your friends...

International String Trio to Perform at Pot au Feu in Providence—A fabulous evening of music, food and wine

RE/MAX Reports 1.3% Increase in Pending RI Home Sales for March—Increase in pending sales, but decrease in home…

 
 

Doctors + Patients Disagree On Depression Recovery—RI Hospital

Monday, November 05, 2012

 

How a recovery, or remission, from depression is defined may be very different, depending on whether you're the patient or the doctor. Photo: S.Hart Photography/flickr.

While your doctor may feel you've recovered from depression, you may not feel that way at all, according to new research from Rhode Island Hospital.

Rhode Island Hospital researcher Mark Zimmerman, M.D., director of outpatient psychiatry, has found that patients suffering from major depressive disorder (MDD) define remission from depression differently than clinicians. While many psychiatrists and clinicians view remission from a symptom-based standpoint, the study found that patients put much more emphasis on life satisfaction and sense of well-being than on actual symptoms. The paper is published online in advance of print in the Journal of Psychiatric Research.

How patients and their doctors differ

“Current standards for treating major depressive disorder recommend that achieving remission should be considered the principal goal of treatment,” said Zimmerman. “But recent studies have shown that patients and clinicians view remission differently. To determine the best approach to achieving a level of remission satisfactory to the patient, we developed the Remission from Depression Questionnaire to measure the components of depression that patients feel are most important.”

A questionnaire to get to the bottom of it

The Remission from Depression Questionnaire (RDQ) includes questions about symptoms of depression, non-depressive symptoms, features of positive mental health, coping ability, functioning, life satisfaction and a general sense of well-being. This is the first study of the reliability and validity of the RDQ. The study concluded that the RDQ is a reliable and valid measure that evaluates multiple domains that depressed patients consider important to determining remission. The results are consistent with prior research, suggesting that depressed patients’ perspective of remission goes beyond symptom resolution.

Two studies were conducted: the first including 100 psychiatric outpatients being treated for DSM-IV MDD in the Rhode Island Department of Psychiatry outpatient practice; and the second examined 274 outpatients receiving ongoing treatment for MDD at the hospital’s outpatient residency training clinic. The Rhode Island Hospital outpatient psychiatric group predominantly treats individuals with medical insurance on a fee-for-service basis, and it is distinct from the hospital’s outpatient residency training clinic that predominantly serves lower income, uninsured and medical assistance patients.

Missing how patients "feel"

The RDQ supports recent findings that suggest that symptom-based definitions of remission used in efficacy studies do not adequately reflect the perspective of depressed patients receiving treatment in route clinical settings.

“More work must be done to broaden the definition of remission,” Zimmerman said. “Our patients need to feel supported, they need to feel confident about their remission. Therefore, it’s imperative that clinicians and patients work more closely together to more clearly define remission in order to achieve the best outcomes for these patients. If some of the symptoms appear to be alleviated, but the patient is still suffering from a poor sense of well-being and low life satisfaction, then there is still more work to do.”

The study was funded by a grant from Eli Lilly USA, LLC. Zimmerman’s principal affiliation is Rhode Island Hospital, a member hospital of the Lifespan health system in Rhode Island.  He also has an academic appointment at The Warren Alpert Medical School of Brown University, department of psychiatry. Other researchers from Lifespan and The Alpert Medical School involved in the study are Jennifer Martinez, B.A.; Naureen Attiullah, M.D.; Michael Friedman, M.D.; Cristina Toba, M.D.; Daniela Boerescu, M.D.; and Moataz Ragheb, M.D.

 

Related Articles

 

Enjoy this post? Share it with others.




Write your comment...

You must be logged in to post comments.